Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |